{
    "Trade/Device Name(s)": [
        "BBL Sensi-Disc Antimicrobial Susceptibility Test Disks Telavancin 30 \u03bcg",
        "BBL\u2122 Sensi-Disc\u2122 Telavancin 30 \u03bcg"
    ],
    "Submitter Information": "Becton Dickinson and Company",
    "510(k) Number": "K100722",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JTN"
    ],
    "Summary Letter Date": "March 12, 2010",
    "Summary Letter Received Date": "March 15, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1620"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Disc"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus",
        "Streptococcus pyogenes",
        "Enterococcus faecalis",
        "Streptococcus agalactiae",
        "Streptococcus anginosus group",
        "Enterococcus faecium",
        "Staphylococcus haemolyticus",
        "Streptococcus dysgalactiae subsp. equisimilis",
        "Staphylococcus epidermidis"
    ],
    "Specimen Type(s)": [
        "Bacterial culture isolate"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Agar diffusion susceptibility test",
        "Disk diffusion"
    ],
    "Methodologies": [
        "Agar diffusion",
        "Zone diameter measurement",
        "Categorical interpretation (S/I/R)"
    ],
    "Submission Type(s)": [
        "Disk",
        "Antimicrobial susceptibility test"
    ],
    "Document Summary": "FDA 510(k) summary for BBL Sensi-Disc Telavancin 30 \u03bcg paper disk for agar diffusion antimicrobial susceptibility testing of gram-positive bacteria",
    "Indications for Use Summary": "In vitro agar diffusion susceptibility testing to determine bacterial susceptibility to Telavancin using BBL Sensi-Disc 30 \u03bcg, active against select gram-positive microorganisms",
    "fda_folder": "Microbiology"
}